-
Jul 9, 2023
-
Investment will help fuel international partnerships, grow IGX Platform functionality, and diversify proposition with new generative AI solutions
Jun 28, 2023
-
PrecisionLife has announced a data access agreement with the University of Oxford to license the Oxford Endometriosis Gene (OXEGENE) dataset with the aim to develop new personalised treatments for endometriosis patients.
Jun 28, 2023
-
Continued clinical validation and Quest Diagnostics agreement fuel patient need; Expanded space supports platform development & prostate cancer test processing
Jun 27, 2023
-
Jun 19, 2023
-
Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production, with an annual capacity of more than 1 billion RMB.
Jun 19, 2023
-
Yourgene Health demonstrates prolonged storage of blood in EDTA tubes is compatible with NIPT when using size selection to enrich fetal fraction.
Jun 18, 2023
-
Amerigo Scientific launches its ultra-low temperature freezers with a temperature range from -40°C to -86°C.
Jun 16, 2023
-
Collaboration marks step forward in realizing the promise of precision medicine
Jun 19, 2023
-
Jun 16, 2023
-
AntlerA Therapeutics has announced a strategic collaboration and licensing agreement with EyeBio to begin clinical testing of AntlerA's Norrin/Wnt-agonist, a treatment of leaky blood vessels in the eye.
Jun 14, 2023
-
Jun 13, 2023
-
Jun 11, 2023
-
Jun 19, 2023
-
Jun 14, 2023
-
Creative Biolabs released exhibition highlight moments from their booth 2548 at the 2023 BIO International Convention held from June 5 to 8.
Jun 15, 2023
-
PrecisionLife and Nanopharmaceutics, Inc. has announced today a strategic collaboration aiming to accelerate and de-risk the development of Nanopharmaceutics’ portfolio of central nervous system assets.
Jun 14, 2023
-
Jun 13, 2023
-
Jun 13, 2023
-
SMi Systems has disclosed a £6m seed funding round to develop and prove the utility of a novel multi-omic platform for in vitro diagnosis and biomedical research.
Jun 13, 2023